AU2002344252A1 - Mammalian diabetes-mediating proteins - Google Patents

Mammalian diabetes-mediating proteins

Info

Publication number
AU2002344252A1
AU2002344252A1 AU2002344252A AU2002344252A AU2002344252A1 AU 2002344252 A1 AU2002344252 A1 AU 2002344252A1 AU 2002344252 A AU2002344252 A AU 2002344252A AU 2002344252 A AU2002344252 A AU 2002344252A AU 2002344252 A1 AU2002344252 A1 AU 2002344252A1
Authority
AU
Australia
Prior art keywords
mediating proteins
diabetes
mammalian
mammalian diabetes
mediating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002344252A
Inventor
Stephen J. Fey
Allan E. Karlsen
Peter Mose Larsen
Jorn Nerup
Thomas Sparre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syddansk Universitet
Original Assignee
Syddansk Universitet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syddansk Universitet filed Critical Syddansk Universitet
Publication of AU2002344252A1 publication Critical patent/AU2002344252A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002344252A 2001-05-29 2002-05-29 Mammalian diabetes-mediating proteins Abandoned AU2002344252A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200100852 2001-05-29
DKPA200100852 2001-05-29
DKPA200200446 2002-03-22
DKPA200200446 2002-03-22
PCT/DK2002/000368 WO2002097441A2 (en) 2001-05-29 2002-05-29 Mammalian diabetes-mediating proteins

Publications (1)

Publication Number Publication Date
AU2002344252A1 true AU2002344252A1 (en) 2002-12-09

Family

ID=26069028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002344252A Abandoned AU2002344252A1 (en) 2001-05-29 2002-05-29 Mammalian diabetes-mediating proteins

Country Status (3)

Country Link
EP (1) EP1421390A2 (en)
AU (1) AU2002344252A1 (en)
WO (1) WO2002097441A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071338A3 (en) * 2002-03-20 2009-07-22 Pride Proteomics A/S Human diabetes-mediating proteins
FR2910025A1 (en) * 2006-12-19 2008-06-20 Biomerieux Sa METHOD FOR THE DIAGNOSIS OF DIABETES
EP2419536A4 (en) * 2009-04-14 2012-09-05 Merck Sharp & Dohme Microrna as a biomarker of pancreatic islet beta-cell engagement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269744A1 (en) * 1996-10-25 1998-05-07 Peter Mose Larsen Proteome analysis for characterization of up- and down-regulated proteins in biological samples
EP1185862A2 (en) * 1999-06-01 2002-03-13 Proteome Sciences Plc Method and compositions relating to insulin resistance disorders
GB9914890D0 (en) * 1999-06-25 1999-08-25 Univ Buckingham Methods and compositions relating to pancreatic islet and -cell dysfunction

Also Published As

Publication number Publication date
WO2002097441A3 (en) 2004-03-25
WO2002097441A2 (en) 2002-12-05
EP1421390A2 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
AU2001271589A1 (en) Mammalian secreted proteins
AU2002361452A1 (en) Secreted proteins
AU2002353227A1 (en) Secreted proteins
AU2002342010A1 (en) Secreted proteins
AU2002354502A1 (en) Fluorescent proteins
AU2002354803A1 (en) Secreted proteins
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002255733A1 (en) Secreted proteins
AU2002252700A1 (en) Secreted proteins
AU1881200A (en) Novel proteins
AU2061201A (en) Mammalian dishevelled-associated proteins
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2002258657A1 (en) Secreted proteins
AU2002327533A1 (en) Secreted proteins
AU2002329201A1 (en) Lp354 mammalian secreted protein
AU2002357850A1 (en) Neurotransmission-associated proteins
AU2002355016A1 (en) Postsynaptic proteins
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2002324769A1 (en) Physalia fluorescent proteins
AU2002326909A1 (en) Neurotransmission-associated proteins
AU2002357873A1 (en) Carbohydrate-associated proteins
AU2001241044A1 (en) Mitf-associated proteins
AU2002328115A1 (en) Phosphatidylinositol 5-phosphate-binding proteins
AU2002229561A1 (en) Fluorescent proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase